Winning Health Technology Group Co.,Ltd. Class A

Winning Health Technology Group Co.,Ltd. Class A

SSZSE:300253
6.51
CNY
-0.12
(-1.81%)
-0.18EPS
15.36BMarket Cap
Apr 21Next Earn

Total Valuation

CNY

As of September 30, 2026, Winning Health Technology Group Co.,Ltd. Class A carries a market capitalization of 15.36B, placing it among publicly traded companies globally. Its enterprise value stands at 15.03B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap15.36B
Enterprise Value15.03B

Important Dates

Winning Health Technology Group Co.,Ltd. Class A's next confirmed earnings release is scheduled for April 21, 2027.

Earnings Date4/21/2027

Share Statistics

As of September 30, 2026, Winning Health Technology Group Co.,Ltd. Class A has 2.20B shares outstanding.

Shares Outstanding2.20B

Valuation Ratios

These figures are as of September 30, 2026. The price-to-sales ratio is 6.72, and the price-to-book ratio stands at 2.81.

PS Ratio6.72
PB Ratio2.81
P/TBV Ratio4.35

Enterprise Valuation

These figures are as of September 30, 2026. The EV/Sales ratio of 6.55 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 15.03B versus a market cap of 15.36B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales6.55

Financial Position

As of September 30, 2026, Winning Health Technology Group Co.,Ltd. Class A maintains a current ratio of 1.75, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 22.00, indicating elevated leverage, while an interest coverage ratio of -6.56 demonstrates limited ability to service its debt obligations.

Current Ratio1.75
Quick Ratio0.59
Debt / Equity22.00
Debt / EBITDA-2.56
Interest Coverage-6.56

Financial Efficiency

CNY

Over the twelve months ended September 30, 2026, Winning Health Technology Group Co.,Ltd. Class A posted a negative return on equity (ROE) of -6.58, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -4.48, reflecting losses generated across the asset base. The company generates approximately 411,586.87 in revenue per employee across its workforce of 5,570.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 13.00 indicates how many times Winning Health Technology Group Co.,Ltd. Class A sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)-6.58
Return on Assets (ROA)-4.48
Revenue Per Employee411,586.87
Employee Count5,570.00
Inventory Turnover13.00

Taxes

CNY

Over the twelve months ended September 30, 2026, Winning Health Technology Group Co.,Ltd. Class A recorded an income tax benefit of -36.24M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -436.55M and -373.05M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax-36.24M

Stock Price Statistics

CNY

As of the close on November 17, 2026, Winning Health Technology Group Co.,Ltd. Class A's stock has declined approximately 19.53% over the past 52 weeks. The 50-day moving average sits at 6.96, while the 200-day moving average is 8.11.

52-Week Price Change-19.53%
50-Day Moving Average6.96
200-Day Moving Average8.11

Income Statement

CNY

Over the twelve months ended September 30, 2026, Winning Health Technology Group Co.,Ltd. Class A generated 2.29B in revenue and converted that into -373.05M in net income, yielding earnings per share of -0.18. EBITDA reached -469.02M, while operating income came in at -95.32M.

Revenue2.29B
Gross Profit779.69M
Operating Income-95.32M
Pretax Income-436.55M
Net Income-373.05M
EBITDA-469.02M
EBIT-469.02M
Earnings Per Share (EPS)-0.18

Balance Sheet

CNY

As of September 30, 2026, Winning Health Technology Group Co.,Ltd. Class A holds 1.52B in cash and equivalents against 1.20B in total debt, resulting in a net debt position of -1.51B. Total book value stands at 5.47B, with working capital of 1.94B providing operational flexibility.

Cash & Cash Equivalents1.52B
Total Debt1.20B
Net Debt-1.51B
Equity (Book Value)5.47B
Book Value Per Share2.48
Working Capital1.94B

Cash Flow

CNY

These figures cover the twelve months ended September 30, 2026.

Capital Expenditures-162.02M

Margins

Over the twelve months ended September 30, 2026, Winning Health Technology Group Co.,Ltd. Class A posted a gross margin of 34.01, reflecting its pricing power and cost economics. The operating margin of -4.16 and net profit margin of -16.27 provide insight into operational efficiency.

Gross Margin34.01
Operating Margin-4.16
Pretax Margin-19.04
Profit Margin-16.27
EBITDA Margin-20.46

Dividends & Yields

CNY

Over the twelve months ended September 30, 2026, Winning Health Technology Group Co.,Ltd. Class A paid dividends of 0.01 per share. The dividend payout ratio of -4.22 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield reaches 0.65, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Winning Health Technology Group Co.,Ltd. Class A shareholders.

Dividend Per Share0.01
Payout Ratio-4.22
Shareholder Yield0.65

Stock Splits

Winning Health Technology Group Co.,Ltd. Class A's most recent stock split took place on June 22, 2020 with a 10:13 split ratio.

Last Split Date6/22/2020
Split Ratio10:13

Scores

As of September 30, 2026, Winning Health Technology Group Co.,Ltd. Class A has an Altman Z-Score of 4.56, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score4.56